Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seletracetam in Refractory Partial Onset Seizures
NCT00422110Phase 3Withdrawn
- Sponsor
- UCB
- Start
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of seletracetam in focal onset seizure, sponsored by UCB. Planned start May 2008; status: withdrawn.
02
Drugs
seletracetam
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00422110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422110.